ShareThis

Translate to ...... with one click.

CURRENT EVENTS:


Dec.2014 LauraHillenbrand FaceTheNation
ME+Unbroken Interview HERE -

AND
Dec 2014 ~ "NIH"P2P4ME"

NIH="InsufficientResearch"=DUH !
Treatment= more"SELF Management"
DraftReport HERE
AND
Nov.2014- "Plague"-Published !!
VOA-PodcastAudioInterview HERE
Hardcover+Kindle+AudioBook
Amazon USA Link HERE









Showing posts with label CFIDS. Show all posts
Showing posts with label CFIDS. Show all posts

Wednesday, March 2, 2011

#105 ~ The Transforming Faces of the CAA

The Transforming Faces of the CFIDS Association of America

Posted on March 1, 2011

Guest blog: RePosted with Permission of the Author :
by John Herd


In the early years of the CFIDS Association of America (CAA) the organization was a dynamic organization, doing its best to represent and help patients.

As Kim McCleary became more entrenched in the CAA, taking over increasingly more control of it, their [her] advocacy still began to change. Instead of acting as a diplomatic advocate trying to make advocacy headway with government officials and agencies, her actions and statement about health department activities and/or lack there of were becoming increasingly anemic.

Effective diplomacy is one thing, but increasingly respected advocates and informed patients were talking about McCleary being “in bed with the health department.”

At the same time it was becoming increasingly evident that (A) McCleary was not willing to work collaboratively with other CFS organizations or advocates, (B) that the CAA was no longer interested in providing any kind of services to aid or assist patients, and (C) that the CAA’s actions were all about what was economically best for the CAA, in McCleary’s mind.

McCleary was consolidating her power within the CAA and in the governmental CFS arena. She made a point of selecting various CAA board members who would accept her views about matters and back her up. So too was she making sure she had an inside track to health department committees and officials while doing nothing to assist other advocates, activists or patient organizations with advocacy initiatives. She was not what one would call a team player, unless of course the team one is referring to is the health department.

A high level health department official when speaking to a group about a CFS advocacy said, “When (_____) speaks (this person) speaks for the patients; when Kim speaks she speaks for her organization.” That clearly defines what McClearly has been about.

Due to personal matters the founder of the CAA, Marc Iverson, had less of a hand in running the organization. Additionally, McCleary had consolidated so much power on the organization’s board that Marc found he had diminished influence upon getting the organization back on track. Marc had his ideas about CFS advocacy and helping patients, McCleary had hers, and the differences were vast.

I can not reveal the details because they were shared in confidence, but the internal wrangling within the CAA got very ugly. Marc eventually composed a resignation letter and left the organization.

In 2004 Jon Sterling, who had become the CAA’s Chairman of the Board and several other people resigned for similar reasons. What lead up to that event seemed like a tactical carbon copy of the playbook used against Marc Iverson. Again the conflicts came down to doing what would most effectively be representing and acting on behalf of the CFS community or following McCleary’s strategies for building CAA’s sphere of influence with the health department.

McCleary’s style of impotent advocacy was taking a profoundly negative toll on the organization’s membership roster and donations to the organization. The organization’s excuse for declining membership was that much of the information it had once furnished was now available on the Internet. That excuse was nonsense; people did not feel the organization was adequately representing them.

The CAA had never made enough money from membership funds to run the organization, and clearly not enough to fund the large salary McCleary wanted for herself. She desperately needed a revenue stream and the answer was health department contracts.

For those of us in the CFS advocacy trenches that immediately reeked of conflict of interest and we said so. Given the CAA’s economic dependence on those contracts the CAA was not about to bite the hand that fed them. The messages coming from the CAA increasingly sounded as if the health department had written them. The CAA had become the CDC’s puppet.

When it became clear to McCleary that the CDC contracts were ending she needed to find a new revenue stream. Since the contracts were ending anyway she made the tactical decision to distance herself and the CAA from CDC with a series of critical statements about the CDC. Such distancing was important for her next metamorphic transformation of the CAA, that of becoming an administrative medical research network.

The CAA brought on board Suzanne Vernon from the CDC to act as their Scientific Director.

Having read the CAA’s “Research Grants Program, Request for Applications” http://www.cfids.org/profresources/2008rfa.pdf and the CAA’s “Research Grants: Guidelines, Guidelines for Conducting CFS Research Studies” http://www.cfids.org/profresources/grants-guidelines.asp it was evident that McCleary and Vernon were trying to make the CAA an administrative medical research network.

Cort Johnson, the most outspoken, ardent supporter of the CAA immediately was highly critical of me when I publicly pointed this out. He said there was no evidence to support my analysis of what the CAA was doing.

When one CFS advocate not long ago referred to the CAA as being an advocacy organization to an NIH official, she reportedly was immediately corrected by the official that the CAA is not an advocacy organization, they are a research organization. The official most likely would not have stated that if that were not the way the CAA were portraying themselves.

It would not surprise me at all to see the CAA eventually applying for government funding directly, and if need be changing their incorporation type in order to do so.

So here we are today. The CAA was not only luke warm at best about the Whittemore Peterson Institute’s (WPI) XMRV findings, they have reportedly been very aggressively speaking and acting behind the scenes to blackball WPI from meetings, government committees and grant funding. The only logical conclusion one can draw from this is that the CAA views WPI as a research competitor. For this advocate, I have far more faith in the WPI and the medical network they have been forming than in the CAA and whatever directions they wish to steer CFS research.

I do not feel the CAA is adequately representing the bests interests of the CFS community as an advocacy organization or a research organization. The vast majority of those I speak to do not want the CAA to convey that that they are representing us when they are not doing so. While a small number of people have been critical of our speaking out about this, claiming we need the CAA because they are the only national organization, my position is that having no organization is better than one that is doing harm. If the CAA went under that may clear the way for patients to get behind creating the kind of advocacy organization we need and getting the kind of support and funding the
WPI needs.



© John Herd, ’11
johnherd@johnherd.com
Original Article 

ShareThis

Monday, February 1, 2010

#50~ CFS says BBye Reeves at CDC, ~ and Mikovits/Bell videos

My, my... there has just been TOO much News and for once "This is a GOOD Thing" my relapse from the excitement tho.. not so good.


Since my last post we have had 2 BIG Lecture/Presentations (videos below) and FINALLY after YEARS of Disgust and "United Complaints" one of our Goals to help our Research in the USA move Forward and be led by a Scientist that KNOWS something is almost
here....


"Change of leadership" ANNOUNCED for **CDC’s ~ CFS Research Program**
**********************************************************
The U.S. Centers for Disease Control and  Prevention (CDC) has announced that Dr. William C. Reeves, head of the agency’s CFS Research Program, will be taking a new position within the agency

effective Feb. 14, 2010 (Happy Valentine's Day)
and that "he will no longer lead" the agency’s CFS research. 

Dr. Elizabeth Unger will serve as  "acting chief" of the Chronic Viral 
Diseases Branch, the unit within CDC that houses the CFS Research Program. On Feb. 14, Dr. Reeves will begin an assignment as Senior Advisor for Mental Health Surveillance in the Public Health Surveillance Program Office within the CDC’s Office of Surveillance, Epidemiology, and Laboratory Services.

Do we need to actually mention just HOW hilarious this actually IS ?
For YEARS, he has been the one to say that WE were ONLY depressed and that there were NO biomarkers for CFS, when actually HE was probably the ONLY one that believed thatand needed "Mental Help" as he has been in Total Denial of the Truth for many decades and could USE
some Mental Health Intervention himself...  LOL
**********************
Bio of Dr. Elizabeth R. Unger


Unfortunatley, like Dr. Suzanne Vernon now with the CFIDS Association, 

Dr. Elizabeth (Beth) R. Unger PhD, MD  was originally doing research for the CDC in Human Papillomavirus Program which was under Dr. William C. Reeves. (Hopefully HE didn't have much influence over her thoughts and she kept an Open Independent Mind.)

A native of Pennsylvania, Dr. Elizabeth  R. Unger received her bachelor’s degree in chemistry from Lebanon Valley College (Annville, PA). She received her doctorate in experimental pathology and medical degree from The University of Chicago. 


After completing her residency in anatomic pathology at The University 
of Chicago and The Milton S. Hershey Medical Center, Pennsylvania State University, she was certified by the American Board of Pathology in 
Anatomic Pathology.

She was a post-doctoral research fellow of the American Cancer Society and The W.W. Smith Charitable Trust in the pathology department of The M.S. Hershey Medical Center and joined the faculty of the Emory University School of Medicine as an academic surgical pathologist in 1990. While there she was involved in several studies associating 

EBV with various cancers.

She accepted a position at the Centers for Disease Control and Prevention in 1994 and became the Team Leader of the Human Papillomavirus (HPV) Program in the Viral Exanthems and Herpesvirus 

Branch of the Division of Viral and Rickettsial Diseases, National Center 
for Infectious Diseases.

Dr. Unger’s research interests have been in molecular diagnostics, viral oncogenesis and molecular epidemiology and she pioneered colorimetric in situ hybridization methods for detection of HPV in diagnostic

samples. The HPV program utilizes a multidisciplinary team to conduct 
laboratory-based epidemiologic research to inform control strategies to reduce the incidence of new HPV infections as well  as the major HPV-associated chronic diseases such as cervical cancer and recurrent respiratory papillomatosis. They worked with the National Cancer 
Institute’s Early Detection Research Network to discover and validate novel molecular markers to improve cervical cancer screening.

In 2000, she first appeared as an author on a CFS study. Chronic fatigue syndrome is not associated with expression of endogenous retroviral p15E. Gelman IH, Unger ER, Mawle AC, Nisenbaum R, Reeves WC.Mol Diagn. 2000 Jun;5(2):155-6.

(huummmm....)

Dr. Unger is a member of the College of American Pathologist’s 
Committee on Molecular Pathology and a founding member of the 
Association for Molecular Pathology. 

She is on the Council of the American Society for Investigative Pathology and The Histochemical Society as well as a principle scientist with the 
American Society of Microbiology. She has served as an advisor to the 
FDA and WHO on HPV testing and vaccine issues. She is on the editorial board of four journals including Technology in Cancer Research and Treatment.

Centers for Disease Control and Prevention 
1600 Clifton Rd Mail Stop G41, NE
Atlanta, GA 30333.
Div. of Viral and Rickettsial Diseases
E: eru0@cdc.gov 

We PRAY she will be True to her Hippocratic Oath, unlike her predecessor. May we send her *Good Thoughts* this Valentine's Day and HOPE that she will be ever searching for the REAL cause of this nasty
disease and Help us and the  Entire world eradicate this  illness that is ruining families as well as individuals and costing ALL of our countries economies & families TONS of $$$ in loss of productive energy as we ALL
WANT to be Healthy and able to work and FEEL like functional humans
again... We are NOT "simply depressed." WE have many thing we WANT to do.. May she HELP us reach that Goal.

*********************************************************

ON a Lighter note..  a "non-commercial break here" 
to Remind you.. that  People ARE getting BETTER right now
from this illness because of the Research that is being done... 
so KEEP Dreaming and Keep wishing... and your Dreams
WILL be answered.......



**********************************************************
Now for the Santa of CFS ~ God luv him ♥

 "XMRV retrovirus and CFS,  ME (Myalgic Encephalomyelitis), 
Fibromyalgia and aggressive prostate cancer" 

David S. Bell, MD, FAAP, a Harvard graduate, with an MD degree from 
Boston University School of Medicine in 1971 has come out of retirement to lecture and research XMRV (xenotropic murine leukemia virus-related virus).

The U.S. Dept. of Health and Human  Services appointed Dr. Bell to "Chair" the CFSAC committee from 2003 - 2005.



Dr. David S. Bell's XMRV Presentation
from Barborka on Vimeo


********************************************************************
On January 22, Dr. Judy Mikovits, PhD, director of research for the 
Whittemore Peterson Institute for Neuro-Immune Disease, conducted 
a 2½-hour XMRV seminar in Santa Barbara, CA.

The patient-oriented event was sponsored by the HHV-6 Foundation 

and ProHealth.com, and was introduced by WPI Founder and President 
Annette Whittemore.

This highly informative presentation and Q and A cover a multitude of intriguing details and plans that patients and researchers worldwide have been speculating about for months, since discovery of the XMRV retrovirus in ME/CFS patients’ blood was reported last October in the journal "Science."


Please BE Prepared to Concentrateso put your legs UP and get comfortable.  You can replay this later to take notes 
if you wish.... Just Listen this 1st time.


Dr. Judy Mikovits XMRV Presentation
from ProHealth on Vimeo




Dr. Judy Mikovits XMRV Q and A
from ProHealth on Vimeo


There is even MORE news to Come...but that is ALL I will put in this post.
So let this soak IN and then we will move on to the next set of news releases, OK?

If you have any opinions or comments to share..Please DO.. and PLEASE
SHARE the videos with your friends & family that need to learn MORE
about what ME/CFS is and what the discovery of XMRV means to us.

Saturday, September 26, 2009

#5- Like I said, I've been diagnosed OUT of the system


In a message dated 9/23/2009 2:53:07 P.M. 
PDT, GAILRONDA@AOL.COM writes:

In response to a letter and e-mail that the National CFIDS Foundation  sent to the Centers for Disease Control and Prevention (CDC), a call was  received from Sarah Wiley, the Associate Director of Policy at the center that  houses the CFS program.  The posting that had our name as one of the organizations that provided input into the CFS 5-Year Strategic Plan will be removed sometime today, she said..  


We also discussed that the CDC is not addressing Myalgic Encephalomyelitis (ME) and she understood that was "a bigger concern" and she hopes to address that eventually. 
(The CDC stated, in their "Overview of CFS" that neither CFIDS nor ME should be confused with ME and the National CFIDS Foundation is referring to ME with their name of CFIDS. Currently, it has no diagnostic code in the United States making the diagnosis of ME impossible in this country.)
For better health for all those with CFIDS/ME,

Gail Kansky
President, National CFIDS Foundation, Inc.
103 Aletha Rd.
Needham, MA 02492-3931
781-449-3535 


http://www.NCF-NET.org
(http://www.NCF-NET.org)